Invesco Ltd. - IRONWOOD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Invesco Ltd. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$4,753,000
-60.5%
4,000,000
-55.6%
0.00%
-50.0%
Q2 2017$12,043,000
-3.1%
9,000,000
-10.0%
0.00%0.0%
Q1 2017$12,431,000
+8.6%
10,000,0000.0%0.00%0.0%
Q4 2016$11,444,000
-4.0%
10,000,0000.0%0.00%0.0%
Q3 2016$11,919,000
+16.4%
10,000,0000.0%0.00%0.0%
Q2 2016$10,244,00010,000,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opti Capital Management, LP 11,901$11,946,0002.07%
Context Capital Management, LLC 1,000,000$997,0000.56%
WOLVERINE ASSET MANAGEMENT LLC 33,392,000$33,442,0000.42%
SSI INVESTMENT MANAGEMENT LLC 3,000,000$2,991,0000.22%
CSS LLC/IL 2,876,000$2,883,0000.18%
PALISADE CAPITAL MANAGEMENT, LP 5,000,000$5,016,0000.15%
HBK INVESTMENTS L P 10,116,000$10,186,0000.13%
TENOR CAPITAL MANAGEMENT Co., L.P. 1,817,000$1,835,0000.11%
LINDEN ADVISORS LP 6,269,000$6,290,0000.08%
LAZARD ASSET MANAGEMENT LLC 15,000,000$15,028,0000.02%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders